{
  "paper_metadata": {
    "pmid": "29641532",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on BRCA2 variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": "p.A75P",
      "genomic_position": "rs28897701",
      "clinical_significance": "VUS",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 0,
        "unaffected_count": 1,
        "uncertain_count": 0,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "uncertain",
          "phenotype_details": "not specified",
          "evidence_sentence": "The BRCA2 p.A75P mutation is, however, not classified as predisposing to breast/ovarian cancer by LOVD [19], or ClinVar."
        }
      ],
      "functional_data": {
        "summary": "Predicted as damaging by all four in silico prediction algorithms.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": "<1:2000 in Kaviar",
      "evidence_level": "low",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is not classified as pathogenic.",
      "key_quotes": [
        "The BRCA2 p.A75P mutation is, however, not classified as predisposing to breast/ovarian cancer by LOVD [19], or ClinVar."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": "p.N3024*",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "breast/ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "breast/ovarian cancer",
          "evidence_sentence": "Two of the nonsense mutations (p.C675X and p.E1013X) in BRCA1, 7 of the frameshift (p.N1626*11, p.N3024*16, p.Q1429*8, p.L2092*6, p.K1057*7 (x2), and p.F1546*21) in BRCA2 and a single frameshift (p.Q60*6) in PALB2 would predispose the carrier to breast/ovarian cancer."
        }
      ],
      "functional_data": {
        "summary": "Nonsense mutation leading to premature termination of the protein.",
        "assays": []
      },
      "segregation_data": "Segregates with breast/ovarian cancer in families.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is associated with a high risk of breast/ovarian cancer.",
      "key_quotes": [
        "Two of the nonsense mutations (p.C675X and p.E1013X) in BRCA1, 7 of the frameshift (p.N1626*11, p.N3024*16, p.Q1429*8, p.L2092*6, p.K1057*7 (x2), and p.F1546*21) in BRCA2 and a single frameshift (p.Q60*6) in PALB2 would predispose the carrier to breast/ovarian cancer."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}